Sign in
Taking people in United StatesNo phase

Using daily voice recordings to estimate risk of worsening in heart failure

Tests a voice-based software tool in adults living with chronic heart failure.

Key facts

Who runs it
Noah Labs
Where
Boston, United StatesSee the site
Trial code
Registry title
Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
Status
Recruiting
People taking part
450 people, planned
Started
15 Oct 2026
Expected to end
Dec 2027
Type of study
Observational
Treatments tested
  • Daily Voice Recording
Record updated
27 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 22 or older with Stage C heart failure who had a worsening heart failure event in the last 180 days.

Age
22 years or older
Sex
All sexes can join.
Disease stage
Heart failure, Stage C, with a decompensated heart failure (DHF) event within the prior 180 days.

Main reasons for not taking part

  • Monitored with implantable volume or pressure monitoring devices
  • Planned cardiac surgery or major intervention (for example LVAD or transplant)
  • Unable or unwilling to follow study procedures

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age ≥22
  • HF diagnosis (Stage C)
  • DHF event within prior 180 days

Who cannot take part

  • Planned cardiac surgery or major intervention (e.g., LVAD or transplant), or
  • Monitoring with implantable volume or pressure monitoring devices, or
  • Otherwise inability or unwillingness to comply with study procedures

Where in United States

  • Brigham and Women's HospitalBoston, United StatesContact: Ameesh Isath, MBBSTaking people

About the trial

What the trial wants to find out

VOICE-HF is a clinical study designed to evaluate the performance of a novel non-invasive software device (Noah Labs Vox) that uses vocal characteristics to estimate DHF risk and has strong potential for clinical success. This study will compare the performance of Noah Labs Vox with the contemporary performance of commonly used weight-based remote monitoring rules and applications to determine efficacy and safety.

The group in the trial

  • Voice-Based Monitoring Group

    All participants receive standard heart failure care as per local standard of care, plus daily voice monitoring via a mobile application. Patients record voice samples and answer symptom questions daily. Sites and participants are blinded to the results, which are analyzed retrospectively.

    Treatment: Daily Voice Recording

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
Plain-language title
Using daily voice recordings to estimate risk of worsening in heart failureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
27 October 2026